Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases
Steady-state activation of cardiac β-adrenergic receptors leads to an intracellular compartmentation of cAMP resulting from localized cyclic nucleotide phosphodiesterase (PDE) activity. To evaluate the time course of the cAMP changes in the different compartments, brief (15 seconds) pulses of isopre...
Gespeichert in:
Veröffentlicht in: | Circulation research 2008-05, Vol.102 (9), p.1091-1100 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1100 |
---|---|
container_issue | 9 |
container_start_page | 1091 |
container_title | Circulation research |
container_volume | 102 |
creator | Leroy, Jérôme Abi-Gerges, Aniella Nikolaev, Viacheslav O Richter, Wito Lechêne, Patrick Mazet, Jean-Luc Conti, Marco Fischmeister, Rodolphe Vandecasteele, Grégoire |
description | Steady-state activation of cardiac β-adrenergic receptors leads to an intracellular compartmentation of cAMP resulting from localized cyclic nucleotide phosphodiesterase (PDE) activity. To evaluate the time course of the cAMP changes in the different compartments, brief (15 seconds) pulses of isoprenaline (100 nmol/L) were applied to adult rat ventricular myocytes (ARVMs) while monitoring cAMP changes beneath the membrane using engineered cyclic nucleotide-gated channels and within the cytosol with the fluorescence resonance energy transfer–based sensor, Epac2-camps. cAMP kinetics in the two compartments were compared to the time course of the L-type Ca channel current (ICa,L) amplitude. The onset and recovery of cAMP transients were, respectively, 30% and 50% faster at the plasma membrane than in the cytosol, in agreement with a rapid production and degradation of the second messenger at the plasma membrane and a restricted diffusion of cAMP to the cytosol. ICa,L amplitude increased twice slower than cAMP at the membrane, and the current remained elevated for ≈5 minutes after cAMP had already returned to basal level, indicating that cAMP changes are not rate-limiting in channel phosphorylation/dephosphorylation. Inhibition of PDE4 (with 10 μmol/L Ro 20-1724) increased the amplitude and dramatically slowed down the onset and recovery of cAMP signals, whereas PDE3 blockade (with 1 μmol/L cilostamide) had a minor effect only on subsarcolemmal cAMP. However, when both PDE3 and PDE4 were inhibited, or when all PDEs were blocked using 3-isobutyl-l-methylxanthine (300 μmol/L), cAMP signals and ICa,L declined with a time constant >10 minutes. cAMP-dependent protein kinase inhibition with protein kinase inhibitor produced a similar effect as a partial inhibition of PDE4 on the cytosolic cAMP transient. Consistently, cAMP-PDE assay on ARVMs briefly (15 seconds) exposed to isoprenaline showed a pronounced (up to ≈50%) dose-dependent increase in total PDE activity, which was mainly attributable to activation of PDE4. These results reveal temporally distinct β-adrenergic receptor cAMP compartments in ARVMs and shed new light on the intricate roles of PDE3 and PDE4. |
doi_str_mv | 10.1161/CIRCRESAHA.107.167817 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_18369156</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18369156</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2144-6f53656a4cfaf397db733e11e9988d2146ec96acfe08644324874660aa2ae3053</originalsourceid><addsrcrecordid>eNo9kU1u1EAQhVsIRIbAEUC9YYU8VP-4bbOzTCCRJiLyBLajSrs8NvS0rW6PIl-Eg3AQzoSHBFa1qE_v6b3H2GsBayGMeF9d1VV9sS0vy7WAbC1MlovsCVuJVOpEp5l4ylYAUCSZUnDGXsT4HUBoJYvn7EzkyhQiNSv2czvi1A8THcYhoOMfZ4-H3kY-tPz3r6RsAnkK-95yW17f8G2_9-giR9_wTXI7j8QrlO941aH35HhN-6M7CXree142RzfxGif-jfwUerv8Ar-eBztPFD_wenB0Mrrphjh2Q9NTnChgpPiSPWsXH3r1eM_Z108Xt9Vlsvny-aoqN8kohdaJaVNlUoPattiqImvulrQkBBVFnjcLYsgWBm1LkBu9hNd5po0BRImkIFXn7M2D7ni8O1CzG0N_wDDv_hW0AG8fAYwWXRvQ2z7-5yQoufR-4vQDdz-4JUP84Y73FHYdoZu63TIEKBAykQA5pFBAAn_X-ANwDodr</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Leroy, Jérôme ; Abi-Gerges, Aniella ; Nikolaev, Viacheslav O ; Richter, Wito ; Lechêne, Patrick ; Mazet, Jean-Luc ; Conti, Marco ; Fischmeister, Rodolphe ; Vandecasteele, Grégoire</creator><creatorcontrib>Leroy, Jérôme ; Abi-Gerges, Aniella ; Nikolaev, Viacheslav O ; Richter, Wito ; Lechêne, Patrick ; Mazet, Jean-Luc ; Conti, Marco ; Fischmeister, Rodolphe ; Vandecasteele, Grégoire</creatorcontrib><description>Steady-state activation of cardiac β-adrenergic receptors leads to an intracellular compartmentation of cAMP resulting from localized cyclic nucleotide phosphodiesterase (PDE) activity. To evaluate the time course of the cAMP changes in the different compartments, brief (15 seconds) pulses of isoprenaline (100 nmol/L) were applied to adult rat ventricular myocytes (ARVMs) while monitoring cAMP changes beneath the membrane using engineered cyclic nucleotide-gated channels and within the cytosol with the fluorescence resonance energy transfer–based sensor, Epac2-camps. cAMP kinetics in the two compartments were compared to the time course of the L-type Ca channel current (ICa,L) amplitude. The onset and recovery of cAMP transients were, respectively, 30% and 50% faster at the plasma membrane than in the cytosol, in agreement with a rapid production and degradation of the second messenger at the plasma membrane and a restricted diffusion of cAMP to the cytosol. ICa,L amplitude increased twice slower than cAMP at the membrane, and the current remained elevated for ≈5 minutes after cAMP had already returned to basal level, indicating that cAMP changes are not rate-limiting in channel phosphorylation/dephosphorylation. Inhibition of PDE4 (with 10 μmol/L Ro 20-1724) increased the amplitude and dramatically slowed down the onset and recovery of cAMP signals, whereas PDE3 blockade (with 1 μmol/L cilostamide) had a minor effect only on subsarcolemmal cAMP. However, when both PDE3 and PDE4 were inhibited, or when all PDEs were blocked using 3-isobutyl-l-methylxanthine (300 μmol/L), cAMP signals and ICa,L declined with a time constant >10 minutes. cAMP-dependent protein kinase inhibition with protein kinase inhibitor produced a similar effect as a partial inhibition of PDE4 on the cytosolic cAMP transient. Consistently, cAMP-PDE assay on ARVMs briefly (15 seconds) exposed to isoprenaline showed a pronounced (up to ≈50%) dose-dependent increase in total PDE activity, which was mainly attributable to activation of PDE4. These results reveal temporally distinct β-adrenergic receptor cAMP compartments in ARVMs and shed new light on the intricate roles of PDE3 and PDE4.</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/CIRCRESAHA.107.167817</identifier><identifier>PMID: 18369156</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone - pharmacology ; Adrenergic beta-Agonists - pharmacology ; Animals ; Biological and medical sciences ; Biosensing Techniques ; Calcium Channels, L-Type - metabolism ; Cells, Cultured ; Cyclic AMP - metabolism ; Cyclic AMP-Dependent Protein Kinases - metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism ; Cyclic Nucleotide-Gated Cation Channels - genetics ; Cyclic Nucleotide-Gated Cation Channels - metabolism ; Cytosol - metabolism ; Dose-Response Relationship, Drug ; Enzyme Activation ; Fluorescence Resonance Energy Transfer ; Fundamental and applied biological sciences. Psychology ; Guanine Nucleotide Exchange Factors - genetics ; Guanine Nucleotide Exchange Factors - metabolism ; Heart Ventricles - metabolism ; Isoproterenol - pharmacology ; Kinetics ; Male ; Membrane Potentials ; Microscopy, Fluorescence - methods ; Myocardial Contraction - drug effects ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - enzymology ; Myocytes, Cardiac - metabolism ; Phosphodiesterase 3 Inhibitors ; Phosphodiesterase 4 Inhibitors ; Phosphodiesterase Inhibitors - pharmacology ; Phosphorylation ; Quinolones - pharmacology ; Rats ; Rats, Wistar ; Receptors, Adrenergic, beta - drug effects ; Receptors, Adrenergic, beta - metabolism ; Sarcolemma - metabolism ; Signal Transduction - drug effects ; Transfection ; Vertebrates: cardiovascular system</subject><ispartof>Circulation research, 2008-05, Vol.102 (9), p.1091-1100</ispartof><rights>2008 American Heart Association, Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27906,27907</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20328176$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18369156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leroy, Jérôme</creatorcontrib><creatorcontrib>Abi-Gerges, Aniella</creatorcontrib><creatorcontrib>Nikolaev, Viacheslav O</creatorcontrib><creatorcontrib>Richter, Wito</creatorcontrib><creatorcontrib>Lechêne, Patrick</creatorcontrib><creatorcontrib>Mazet, Jean-Luc</creatorcontrib><creatorcontrib>Conti, Marco</creatorcontrib><creatorcontrib>Fischmeister, Rodolphe</creatorcontrib><creatorcontrib>Vandecasteele, Grégoire</creatorcontrib><title>Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>Steady-state activation of cardiac β-adrenergic receptors leads to an intracellular compartmentation of cAMP resulting from localized cyclic nucleotide phosphodiesterase (PDE) activity. To evaluate the time course of the cAMP changes in the different compartments, brief (15 seconds) pulses of isoprenaline (100 nmol/L) were applied to adult rat ventricular myocytes (ARVMs) while monitoring cAMP changes beneath the membrane using engineered cyclic nucleotide-gated channels and within the cytosol with the fluorescence resonance energy transfer–based sensor, Epac2-camps. cAMP kinetics in the two compartments were compared to the time course of the L-type Ca channel current (ICa,L) amplitude. The onset and recovery of cAMP transients were, respectively, 30% and 50% faster at the plasma membrane than in the cytosol, in agreement with a rapid production and degradation of the second messenger at the plasma membrane and a restricted diffusion of cAMP to the cytosol. ICa,L amplitude increased twice slower than cAMP at the membrane, and the current remained elevated for ≈5 minutes after cAMP had already returned to basal level, indicating that cAMP changes are not rate-limiting in channel phosphorylation/dephosphorylation. Inhibition of PDE4 (with 10 μmol/L Ro 20-1724) increased the amplitude and dramatically slowed down the onset and recovery of cAMP signals, whereas PDE3 blockade (with 1 μmol/L cilostamide) had a minor effect only on subsarcolemmal cAMP. However, when both PDE3 and PDE4 were inhibited, or when all PDEs were blocked using 3-isobutyl-l-methylxanthine (300 μmol/L), cAMP signals and ICa,L declined with a time constant >10 minutes. cAMP-dependent protein kinase inhibition with protein kinase inhibitor produced a similar effect as a partial inhibition of PDE4 on the cytosolic cAMP transient. Consistently, cAMP-PDE assay on ARVMs briefly (15 seconds) exposed to isoprenaline showed a pronounced (up to ≈50%) dose-dependent increase in total PDE activity, which was mainly attributable to activation of PDE4. These results reveal temporally distinct β-adrenergic receptor cAMP compartments in ARVMs and shed new light on the intricate roles of PDE3 and PDE4.</description><subject>4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone - pharmacology</subject><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biosensing Techniques</subject><subject>Calcium Channels, L-Type - metabolism</subject><subject>Cells, Cultured</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic AMP-Dependent Protein Kinases - metabolism</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism</subject><subject>Cyclic Nucleotide-Gated Cation Channels - genetics</subject><subject>Cyclic Nucleotide-Gated Cation Channels - metabolism</subject><subject>Cytosol - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Activation</subject><subject>Fluorescence Resonance Energy Transfer</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Guanine Nucleotide Exchange Factors - genetics</subject><subject>Guanine Nucleotide Exchange Factors - metabolism</subject><subject>Heart Ventricles - metabolism</subject><subject>Isoproterenol - pharmacology</subject><subject>Kinetics</subject><subject>Male</subject><subject>Membrane Potentials</subject><subject>Microscopy, Fluorescence - methods</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - enzymology</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Phosphodiesterase 3 Inhibitors</subject><subject>Phosphodiesterase 4 Inhibitors</subject><subject>Phosphodiesterase Inhibitors - pharmacology</subject><subject>Phosphorylation</subject><subject>Quinolones - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Adrenergic, beta - drug effects</subject><subject>Receptors, Adrenergic, beta - metabolism</subject><subject>Sarcolemma - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Transfection</subject><subject>Vertebrates: cardiovascular system</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU1u1EAQhVsIRIbAEUC9YYU8VP-4bbOzTCCRJiLyBLajSrs8NvS0rW6PIl-Eg3AQzoSHBFa1qE_v6b3H2GsBayGMeF9d1VV9sS0vy7WAbC1MlovsCVuJVOpEp5l4ylYAUCSZUnDGXsT4HUBoJYvn7EzkyhQiNSv2czvi1A8THcYhoOMfZ4-H3kY-tPz3r6RsAnkK-95yW17f8G2_9-giR9_wTXI7j8QrlO941aH35HhN-6M7CXree142RzfxGif-jfwUerv8Ar-eBztPFD_wenB0Mrrphjh2Q9NTnChgpPiSPWsXH3r1eM_Z108Xt9Vlsvny-aoqN8kohdaJaVNlUoPattiqImvulrQkBBVFnjcLYsgWBm1LkBu9hNd5po0BRImkIFXn7M2D7ni8O1CzG0N_wDDv_hW0AG8fAYwWXRvQ2z7-5yQoufR-4vQDdz-4JUP84Y73FHYdoZu63TIEKBAykQA5pFBAAn_X-ANwDodr</recordid><startdate>20080509</startdate><enddate>20080509</enddate><creator>Leroy, Jérôme</creator><creator>Abi-Gerges, Aniella</creator><creator>Nikolaev, Viacheslav O</creator><creator>Richter, Wito</creator><creator>Lechêne, Patrick</creator><creator>Mazet, Jean-Luc</creator><creator>Conti, Marco</creator><creator>Fischmeister, Rodolphe</creator><creator>Vandecasteele, Grégoire</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>20080509</creationdate><title>Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases</title><author>Leroy, Jérôme ; Abi-Gerges, Aniella ; Nikolaev, Viacheslav O ; Richter, Wito ; Lechêne, Patrick ; Mazet, Jean-Luc ; Conti, Marco ; Fischmeister, Rodolphe ; Vandecasteele, Grégoire</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2144-6f53656a4cfaf397db733e11e9988d2146ec96acfe08644324874660aa2ae3053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone - pharmacology</topic><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biosensing Techniques</topic><topic>Calcium Channels, L-Type - metabolism</topic><topic>Cells, Cultured</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic AMP-Dependent Protein Kinases - metabolism</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism</topic><topic>Cyclic Nucleotide-Gated Cation Channels - genetics</topic><topic>Cyclic Nucleotide-Gated Cation Channels - metabolism</topic><topic>Cytosol - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Activation</topic><topic>Fluorescence Resonance Energy Transfer</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Guanine Nucleotide Exchange Factors - genetics</topic><topic>Guanine Nucleotide Exchange Factors - metabolism</topic><topic>Heart Ventricles - metabolism</topic><topic>Isoproterenol - pharmacology</topic><topic>Kinetics</topic><topic>Male</topic><topic>Membrane Potentials</topic><topic>Microscopy, Fluorescence - methods</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - enzymology</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Phosphodiesterase 3 Inhibitors</topic><topic>Phosphodiesterase 4 Inhibitors</topic><topic>Phosphodiesterase Inhibitors - pharmacology</topic><topic>Phosphorylation</topic><topic>Quinolones - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Adrenergic, beta - drug effects</topic><topic>Receptors, Adrenergic, beta - metabolism</topic><topic>Sarcolemma - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Transfection</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leroy, Jérôme</creatorcontrib><creatorcontrib>Abi-Gerges, Aniella</creatorcontrib><creatorcontrib>Nikolaev, Viacheslav O</creatorcontrib><creatorcontrib>Richter, Wito</creatorcontrib><creatorcontrib>Lechêne, Patrick</creatorcontrib><creatorcontrib>Mazet, Jean-Luc</creatorcontrib><creatorcontrib>Conti, Marco</creatorcontrib><creatorcontrib>Fischmeister, Rodolphe</creatorcontrib><creatorcontrib>Vandecasteele, Grégoire</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leroy, Jérôme</au><au>Abi-Gerges, Aniella</au><au>Nikolaev, Viacheslav O</au><au>Richter, Wito</au><au>Lechêne, Patrick</au><au>Mazet, Jean-Luc</au><au>Conti, Marco</au><au>Fischmeister, Rodolphe</au><au>Vandecasteele, Grégoire</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>2008-05-09</date><risdate>2008</risdate><volume>102</volume><issue>9</issue><spage>1091</spage><epage>1100</epage><pages>1091-1100</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>Steady-state activation of cardiac β-adrenergic receptors leads to an intracellular compartmentation of cAMP resulting from localized cyclic nucleotide phosphodiesterase (PDE) activity. To evaluate the time course of the cAMP changes in the different compartments, brief (15 seconds) pulses of isoprenaline (100 nmol/L) were applied to adult rat ventricular myocytes (ARVMs) while monitoring cAMP changes beneath the membrane using engineered cyclic nucleotide-gated channels and within the cytosol with the fluorescence resonance energy transfer–based sensor, Epac2-camps. cAMP kinetics in the two compartments were compared to the time course of the L-type Ca channel current (ICa,L) amplitude. The onset and recovery of cAMP transients were, respectively, 30% and 50% faster at the plasma membrane than in the cytosol, in agreement with a rapid production and degradation of the second messenger at the plasma membrane and a restricted diffusion of cAMP to the cytosol. ICa,L amplitude increased twice slower than cAMP at the membrane, and the current remained elevated for ≈5 minutes after cAMP had already returned to basal level, indicating that cAMP changes are not rate-limiting in channel phosphorylation/dephosphorylation. Inhibition of PDE4 (with 10 μmol/L Ro 20-1724) increased the amplitude and dramatically slowed down the onset and recovery of cAMP signals, whereas PDE3 blockade (with 1 μmol/L cilostamide) had a minor effect only on subsarcolemmal cAMP. However, when both PDE3 and PDE4 were inhibited, or when all PDEs were blocked using 3-isobutyl-l-methylxanthine (300 μmol/L), cAMP signals and ICa,L declined with a time constant >10 minutes. cAMP-dependent protein kinase inhibition with protein kinase inhibitor produced a similar effect as a partial inhibition of PDE4 on the cytosolic cAMP transient. Consistently, cAMP-PDE assay on ARVMs briefly (15 seconds) exposed to isoprenaline showed a pronounced (up to ≈50%) dose-dependent increase in total PDE activity, which was mainly attributable to activation of PDE4. These results reveal temporally distinct β-adrenergic receptor cAMP compartments in ARVMs and shed new light on the intricate roles of PDE3 and PDE4.</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>18369156</pmid><doi>10.1161/CIRCRESAHA.107.167817</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7330 |
ispartof | Circulation research, 2008-05, Vol.102 (9), p.1091-1100 |
issn | 0009-7330 1524-4571 |
language | eng |
recordid | cdi_pubmed_primary_18369156 |
source | MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone - pharmacology Adrenergic beta-Agonists - pharmacology Animals Biological and medical sciences Biosensing Techniques Calcium Channels, L-Type - metabolism Cells, Cultured Cyclic AMP - metabolism Cyclic AMP-Dependent Protein Kinases - metabolism Cyclic Nucleotide Phosphodiesterases, Type 3 - metabolism Cyclic Nucleotide Phosphodiesterases, Type 4 - metabolism Cyclic Nucleotide-Gated Cation Channels - genetics Cyclic Nucleotide-Gated Cation Channels - metabolism Cytosol - metabolism Dose-Response Relationship, Drug Enzyme Activation Fluorescence Resonance Energy Transfer Fundamental and applied biological sciences. Psychology Guanine Nucleotide Exchange Factors - genetics Guanine Nucleotide Exchange Factors - metabolism Heart Ventricles - metabolism Isoproterenol - pharmacology Kinetics Male Membrane Potentials Microscopy, Fluorescence - methods Myocardial Contraction - drug effects Myocytes, Cardiac - drug effects Myocytes, Cardiac - enzymology Myocytes, Cardiac - metabolism Phosphodiesterase 3 Inhibitors Phosphodiesterase 4 Inhibitors Phosphodiesterase Inhibitors - pharmacology Phosphorylation Quinolones - pharmacology Rats Rats, Wistar Receptors, Adrenergic, beta - drug effects Receptors, Adrenergic, beta - metabolism Sarcolemma - metabolism Signal Transduction - drug effects Transfection Vertebrates: cardiovascular system |
title | Spatiotemporal Dynamics of β-Adrenergic cAMP Signals and L-Type Ca2+ Channel Regulation in Adult Rat Ventricular Myocytes: Role of Phosphodiesterases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A30%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spatiotemporal%20Dynamics%20of%20%CE%B2-Adrenergic%20cAMP%20Signals%20and%20L-Type%20Ca2+%20Channel%20Regulation%20in%20Adult%20Rat%20Ventricular%20Myocytes:%20Role%20of%20Phosphodiesterases&rft.jtitle=Circulation%20research&rft.au=Leroy,%20J%C3%A9r%C3%B4me&rft.date=2008-05-09&rft.volume=102&rft.issue=9&rft.spage=1091&rft.epage=1100&rft.pages=1091-1100&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/CIRCRESAHA.107.167817&rft_dat=%3Cpubmed_pasca%3E18369156%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/18369156&rfr_iscdi=true |